victoriaantoniou, Author at European Medical Journal - Page 4 of 22

Degenerative Mitral Regurgitation: 10-Year Study Confirms High Survival Rates with Surgical Repair

A decade-long study confirms excellent survival and low reoperation rates for mitral valve repair at high-volume centres.

New Strategy Enhances PD-1 Therapy in Treatment-Resistant Cancers

Blocking GDF-15 with visugromab enhances immune checkpoint therapy, offering new hope for resistant advanced cancers.

Robotic Bronchoscopy Safely Diagnoses Peripheral Lung Lesions

A large, multicentre study has demonstrated that robotic-assisted bronchoscopy is both safe and effective for diagnosing small and peripheral lung lesions.

Contrast-Enhanced Cone-beam Breast CT Helps Predict Lymphovascular Invasion in Breast Cancer

Contrast-enhanced conebeam breast CT imaging features can help identify lymphovascular invasion status in patients with breast cancer, according to recent research.

Higher Genetic Diabetes Risk Predicts Worse Glycaemic Outcomes in Stroke Survivors

Stroke survivors with high genetic risk for type 2 diabetes face poorer blood sugar control, new study reveals.

Study Finds Sickle Cell Trait Not Linked to Exertion-Related Death

New research finds no evidence linking sickle cell trait to acute pain crises or sudden death during exertion.

Broccoli Compound Linked to Improved Blood Sugar Levels in Prediabetes

Researchers have found that sulforaphane, a chemical compound found in broccoli sprouts, can significantly improve blood sugar levels in people with prediabetes.

Enhancing Immunotherapy by Targeting Specific Receptors in Ovarian Cancer

These findings highlight a host-intrinsic mechanism responsible for the failure of PD-L1 blockade in ovarian cancer.

FAME 3 Reveals Sex-Based Differences in PCI vs CABG Outcomes

Women had similar three-year outcomes with FFR-guided PCI and CABG, whereas men had better outcomes with CABG in FAME 3.

Advanced Biomarkers: A New Era in Prostate Cancer Detection

By offering a non-invasive, highly specific approach, MyProstateScore 2.0 enhances clinical decision-making while reducing patient burden.